You have full text access to this Open Access content

Cancer Medicine

All articles accepted from 14 August 2012 are published under the terms of the Creative Commons Attribution License.  All articles accepted before this date, were published under a Creative Commons Attribution Non-Commercial License.

Cover image for Vol. 4 Issue 2

Edited By: Qingyi Wei, M.D., Ph.D.

Online ISSN: 2045-7634

Recently Published Issues

See all

NEW: Read our latest accepted articles!

Subscribe to RSS headline updates from:
Powered by FeedBurner

Meet the Editor

Qingyi Wei

Cancer Medicine Editor-in-Chief

Qingyi WeiDr Wei is a highly published and cited author who is based at one of the world’s leading cancer research centres. His previous editorial work includes a role as a Senior Editor on the AACR journal Cancer Epidemiology, Biomarkers & Prevention.

His primary research interest is to explore and develop biomarkers for molecular epidemiologic study for assessing cancer susceptibility with an emphasis on DNA repair and apoptosis. His research is aimed at identifying individuals at high risk of developing cancer. This allows for personalisation in cancer research, with an aim to achieve primary prevention, early diagnosis and targeted therapies. The biomarker assays used in his lab are used in studies of cancers of the lung, head and neck cancer, skin, and breast.

Dr Wei’s recent works include genome-wide association study of melanoma, miRNA variants in an apoptosis gene and risk of head and neck cancer, DNA repair capacity phenotype and survival of lung cancer patients with chemotherapy,TGFβ1 gene variants and risk of radiation pneumonitis in lung cancer patients with definitive radiotherapy, and functional single nucleotide polymorphism in the MIIP gene and risk of breast cancer.

Read Dr Wei's editorial: ‘Personalized medicine at a prime time for cancer medicine – Introducing Cancer Medicine.

Journal News from Cancer Medicine

Cancer Medicine News

Cancer Medicine Accepts 100th Article

We are delighted that Cancer Medicine has published its 100th article, Herogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer!

Read and learn more about the first 100 articles accepted in Cancer Medicine.

PubMed and MEDLINE:Cancer Medicine articles are deposited into PubMed Central (PMC) upon publication of an online issue and are therefore searchable on PubMed. In addition, Cancer Medicine has recently been accepted for MEDLINE indexing, allowing heightened search capabilities for the journal.

Submit an Article

We would like to invite you to submit your paper to Cancer Medicine. Reasons to submit:

  • High standard, rigorous peer review  
  • International Editorial Board
  • Rapid publication
  • Open access and fully compliant with open access mandates
  • Authors retain copyright
  • Wiley's tradition in publishing excellence

Cancer Medicineis a peer-reviewed, open access, interdisciplinary journal providing rapid publication of cutting-edge research from global biomedical researchers across the cancer sciences, in the areas of, but not limited to, cancer biology, clinical cancer research, and cancer prevention.

Cancer Medicineis a Wiley Open Access journal, one of a new series of peer reviewed titles publishing quality research with speed and efficiency. For further information visit theWiley Open Access website.

Submit a Paper

Cancer Medicine is supported by Leading Journals and Societies

Cancer Medicine Supporting Journals

Cancer Medicine is supported by other journals published by Wiley on behalf of the world's most prestigious cancer societies. The journals listed below support Cancer Medicine and participate in the Manuscript Transfer Program by referring articles of suitable quality and offering authors the option to have their paper, with any peer review reports, automatically transferred to Cancer Medicine.



Published on behalf of


 Cancer Cytopathology 

Cancer Cytopathology 

Published on behalf of


 International Journal of Cancer 

International Journal of Cancer

Published on behalf of


    Cancer Science 

Cancer Science

Published on behalf of 


    American Journal of Hematology 

American Journal of Hematology

Get Updates from Cancer Medicine

Follow Cancer Medicine

Wiley Open Access has a number of social media outlets where you can get updates about Cancer Medicine.

Become a Facebook Fan

Follow us on Twitter

Visit our Blog